Rankings

Market Cap
Revenue
Operating Income
CapEx
Total Assets
Net Assets
Cash on Hand

Sectors

Technology
Healthcare
Financial Services
Consumer Cyclical
Communication Services
Industrials
Consumer Defensive
Energy
Basic Materials
Real Estate
Utilities

Pages

Home
Earnings Calendar
All Sectors
Terms
Privacy

© 2026 Market Cap Arena. All rights reserved.v1.2.31

ACET Q3 2016 Earnings — Adicet Bio, Inc. Revenue & Financial Results | Market Cap Arena

ACETAdicet Bio, Inc.

$70M

Q3 2016 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$128M

Gross Profit

$31M24.1% margin

Operating Income

$9M6.8% margin

Net Income

$4M3.4% margin

EPS (Diluted)

$2.72

QoQ Revenue Growth

+3.4%

Cash Flow

Operating Cash Flow

$11M

Free Cash Flow

$10M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$545M

Total Liabilities

$235M

Stockholders' Equity

$310M

Cash & Equivalents

$73M

Revenue Segments

Human Health

$48M37%

Pharmaceutical Ingredients

$41M32%

Performance Chemicals

$40M31%

← Q2 2016 All Quarters Q4 2016 →